Key Points
- CFO Shelagh Glaser sold 3,657 shares on Dec. 19 at an average of $460.77, generating about $1.685M and reducing her stake by ~17% to 17,842 shares (valued ~ $8.22M).
- Synopsys beat Q4 EPS estimates ($2.90 vs. $2.79) with revenue of $2.25B (+37.8% YoY), set FY2026 EPS guidance of 14.320–14.400, and carries an average analyst target near $562 with a "Moderate Buy" consensus.
- Multiple law firms have filed securities‑class action notices over recent share declines, and the insider sale — plus unconfirmed $2B Nvidia investment chatter — adds litigation and rumor-driven headline risk investors should monitor.
Synopsys, Inc. (NASDAQ:SNPS - Get Free Report) CFO Shelagh Glaser sold 3,657 shares of the firm's stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company's stock, valued at $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Synopsys Stock Performance
NASDAQ:SNPS opened at $481.24 on Tuesday. The business's fifty day moving average is $434.86 and its 200 day moving average is $504.21. The firm has a market cap of $89.39 billion, a price-to-earnings ratio of 60.23, a PEG ratio of 3.86 and a beta of 1.16. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping the consensus estimate of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter last year, the company earned $3.40 EPS. The firm's revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.
Institutional Investors Weigh In On Synopsys
A number of large investors have recently added to or reduced their stakes in the company. Brighton Jones LLC raised its holdings in shares of Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after buying an additional 50 shares in the last quarter. Compound Planning Inc. grew its position in Synopsys by 45.7% during the first quarter. Compound Planning Inc. now owns 746 shares of the semiconductor company's stock valued at $320,000 after acquiring an additional 234 shares during the last quarter. Kestra Advisory Services LLC raised its stake in shares of Synopsys by 3.0% during the first quarter. Kestra Advisory Services LLC now owns 5,572 shares of the semiconductor company's stock worth $2,390,000 after acquiring an additional 161 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its holdings in shares of Synopsys by 0.5% in the 1st quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 29,564 shares of the semiconductor company's stock worth $12,679,000 after acquiring an additional 148 shares during the last quarter. Finally, Smartleaf Asset Management LLC boosted its stake in shares of Synopsys by 8.6% in the 1st quarter. Smartleaf Asset Management LLC now owns 2,333 shares of the semiconductor company's stock valued at $1,022,000 after purchasing an additional 185 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.
Wall Street Analysts Forecast Growth
Several brokerages have commented on SNPS. Piper Sandler cut their price target on shares of Synopsys from $630.00 to $602.00 and set an "overweight" rating for the company in a report on Thursday, December 11th. Needham & Company LLC increased their price objective on Synopsys from $550.00 to $580.00 and gave the stock a "buy" rating in a research report on Thursday, December 11th. Wall Street Zen upgraded Synopsys from a "sell" rating to a "hold" rating in a research report on Saturday, December 13th. Stifel Nicolaus decreased their target price on Synopsys from $650.00 to $550.00 and set a "buy" rating on the stock in a research note on Wednesday, September 10th. Finally, KeyCorp lifted their price target on Synopsys from $575.00 to $600.00 and gave the company an "overweight" rating in a research report on Thursday, December 11th. Eleven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $562.13.
View Our Latest Analysis on Synopsys
Key Headlines Impacting Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Large institutional buying and favorable analyst coverage: recent filings show big quarter‑end additions by Vanguard, Morgan Stanley and BlackRock, and multiple recent buy/overweight ratings with a median price target near $570 — support that can underpin the share rally and liquidity. QuiverQuant: SNPS Opinions (Institutional / Analyst Activity)
- Neutral Sentiment: Social/media chatter about a reported $2 billion Nvidia investment into Synopsys is circulating and fueling optimism about AI/chip‑design synergies — but this appears to be unconfirmed rumor-level chatter; if verified it would be a major positive, otherwise it’s speculative. QuiverQuant: Nvidia investment buzz
- Negative Sentiment: Multiple law firms have filed notices and are soliciting SNPS shareholders for a securities‑class action covering purchases between Dec 4, 2024 and Sep 9, 2025 (lead‑plaintiff deadlines around Dec 30, 2025). The filings allege securities‑law violations tied to a sharp post‑Sept 9 decline — increased litigation risk can pressure the stock and create ongoing headline risk. GlobeNewswire: Lost Money on Synopsys? Join Class Action
- Negative Sentiment: Insider selling: CFO Shelagh Glaser sold 3,657 shares on Dec. 19 at about $460.77 (reducing her stake ~17%). Insider sales can be viewed as a near‑term negative signal even if routine; investors often watch such moves while litigation headlines are active. SEC filing - Insider Sale (Shelagh Glaser)
Synopsys Company Profile
(
Get Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
